The promise and pitfalls of monoclonal antibody therapeutics

被引：24

作者：

Berkower, I

机构：

[1] Laboratory of Immunoregulation, Div. of Allergenic Prod. and P., Ctr. for Biologics, Food and Admin., Bethesda

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 1996年 / 7卷 / 06期

关键词：

D O I：

10.1016/S0958-1669(96)80073-5

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Recent experience has helped io clarify the best ways to use monoclonal antibodies to solve clinical problems. For example, imaging based on tumor antigens, rather than tumor size, will permit early detection of cancer and accurate staging. Blocking receptor-ligand interactions may permit therapeutic intervention in cell growth or function but activity may depend on the choice of an antiligand or antireceptor strategy. Humanized antibodies will achieve greater intensity and duration of therapy, while allowing repeat administration in chronic diseases. (C) Current Biology Ltd ISSN 0958-1669..

引用

页码：622 / 628

页数：7

共 51 条

[1] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].

ARMITAGE, RJ ;

FANSLOW, WC ;

STROCKBINE, L ;

SATO, TA ;

CLIFFORD, KN ;

MACDUFF, BM ;

ANDERSON, DM ;

GIMPEL, SD ;

DAVISSMITH, T ;

MALISZEWSKI, CR ;

CLARK, EA ;

SMITH, CA ;

GRABSTEIN, KH ;

COSMAN, D ;

SPRIGGS, MK .

NATURE, 1992, 357 (6373) :80-82

[2] DETECTION AND STAGING OF SMALL-CELL LUNG-CARCINOMA WITH A TECHNETIUM-LABELED MONOCLONAL-ANTIBODY A COMPARISON WITH STANDARD STAGING METHODS [J].

BALABAN, EP ;

WALKER, BS ;

COX, JV ;

BORDLEE, RP ;

SALK, D ;

ABRAMS, PG ;

SHEEHAN, RG ;

FRENKEL, EP .

CLINICAL NUCLEAR MEDICINE, 1992, 17 (06) :439-445

[3] BIOLOGIC EFFECTS OF ANTI-INTERLEUKIN-6 MURINE MONOCLONAL-ANTIBODY IN ADVANCED MULTIPLE-MYELOMA [J].

BATAILLE, R ;

BARLOGIE, B ;

LU, ZY ;

ROSSI, JF ;

LAVABREBERTRAND, T ;

BECK, T ;

WIJDENES, J ;

BROCHIER, J ;

KLEIN, B .

BLOOD, 1995, 86 (02) :685-691

[4]

Baumgartner J D, 1991, Infect Dis Clin North Am, V5, P915

[5] CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1 [J].

Berkower, I ;

Mostowski, H ;

Bull, TE ;

Murphy, D .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :863-869

[6]

BERKOWER I, 1992, CLIN IMMUNOTOXICOLOG, P83

[7]

BOGARD WC, 1993, J IMMUNOL, V150, P4438

[8] IMAGING LUNG-CANCER WITH RADIOLABELED ANTIBODIES [J].

BREITZ, HB ;

SULLIVAN, K ;

NELP, WB .

SEMINARS IN NUCLEAR MEDICINE, 1993, 23 (02) :127-132

[9] ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR, PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL [J].

BROWN, PS ;

PARENTEAU, GL ;

DIRBAS, FM ;

GARSIA, RJ ;

GOLDMAN, CK ;

BUKOWSKI, MA ;

JUNGHANS, RP ;

QUEEN, C ;

HAKIMI, J ;

BENJAMIN, WR ;

CLARK, RE ;

WALDMANN, TA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2663-2667

[10] DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY [J].

CAPON, DJ ;

CHAMOW, SM ;

MORDENTI, J ;

MARSTERS, SA ;

GREGORY, T ;

MITSUYA, H ;

BYRN, RA ;

LUCAS, C ;

WURM, FM ;

GROOPMAN, JE ;

BRODER, S ;

SMITH, DH .

NATURE, 1989, 337 (6207) :525-531

← 1 2 3 4 5 6 →